SAMPLE6 TECHNOLOGIES, INC.

Agritech · Still private

Engineered bacteriophages with luminescent enzyme induction for rapid Salmonella detection in food

Claim this profile

Follows are private to you and power your alerts

Updated · sample6.com

Sector
Agritech
Total capital
$1.6M
Federal grants
$1.6M
3 awards · 2015–2017
Rank in peer group#7 of 27
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
17 pending · first 2016
Rank in peer group#3 of 27

Capital timeline

201520162017FEDERAL ↑EQUITY ↓Cumulative $1.6M$150K$995K$490K
201520162017FEDERAL ↑EQUITY ↓Cumulative $1.6M$150K$995K$490K

Latest events

  • Federal grantHealth and Human S · Phase II · Enrichment-free Salmonella detection for food safety$490K
  • Federal grantHealth and Human S · Phase II · Adaptation of an enrichment-free Listeria diagnostic to food matrices$995K
  • Federal grantHealth and Human S · Phase I · Adaptation of enrichment-free Listeria diagnostic to food matrices$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 27 peers

Line = median

Agritech · Molecule

  • Federal grants#7 · top 26%
  • Granted patents#3 · top 11%
  • Linked publications#2 · top 7%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 20
Show all 20 patent records
  • Phage-based Bacterial Detection AssayNov 28, 2017 · US 9,828,625Granted
  • Methods of Making Recombinant Phage, Compositions and Articles of Manufacture of Same for Bacterial DetectionMay 17, 2016 · US 9,340,817Granted
  • Recombinant Phage And MethodsMay 5, 2016 · Application 14990274Pending
  • Recombinant Phage And MethodsJan 12, 2016 · US 9,234,227Granted
  • Codon-optimized Recombinant Phage And Methods Of Using SameApplication PCTUS2015029992Pending
  • Recombinant Phage and Detection Methods using SameApplication 62086445Pending
  • Microbial Detection CompositionsApplication 62053481Pending
  • Microbial Detection CompositionsApplication 62044082Pending
  • Recombinant Phage And Methods Of Detecting ListeriaApplication 62191229Pending
  • Phage-based Bacterial Detection AssayApplication PCTUS2014043190Pending
  • Recombinant Phage And Methods Of Detecting ListeriaApplication 62191867Pending
  • Recombinant Phage And MethodsApplication 61884946Pending
  • Phage-based Microbial DetectionApplication 61884931Pending
  • Phage-based Microbial DetectionApplication 61884935Pending
  • Microbial Detection AssayApplication 61879640Pending
  • System For On-site Environment MonitoringApplication PCTUS2013054433Pending
  • Phage-based Bacterial Detection Assay And SystemApplication 61844399Pending
  • Phage-based Bacterial Detection AssayApplication 61837152Pending
  • Recombinant Phage And MethodsApplication PCTUS2012057214Pending
  • Recombinant Phage And Methods Of Detecting ListeriaApplication PCTUS2016041529Pending

Recent research by its founders

  • Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations202119 cites
  • Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations202113 cites
  • Commercialization of Phage Therapeutics: the Value of Intellectual Property and Patents20200 cites

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .